Radiation Therapy News and Research

RSS

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.

IsoRay third fiscal quarter sales increase 17%

IsoRay Inc., announced financial results for the third fiscal quarter ended March 31, 2011 underscoring significant improvements in quarterly sales revenue growth both sequentially and in the prior year quarter. Sales increased 17% in the period with the Company posting a 581% gain in gross profit compared to the prior year third quarter.

16 May 2011

Young scientists receive Intel Foundation top prize for groundbreaking cancer work

Matthew Feddersen and Blake Marggraff from Lafayette, Calif. were awarded the top prize at the Intel International Science and Engineering Fair, a program of Society for Science & the Public. They received $75,000 and the Gordon E. Moore Award, in honor of the Intel co-founder and retired chairman and CEO, for developing a potentially more effective and less expensive cancer treatment that places tin metal near a tumor before radiation therapy.

16 May 2011

Sosei acquires rights to Loramyc in Japan from BioAlliance Pharma

Sosei Group Corporation, the biopharmaceutical company, today announces that Sosei Co., Ltd., its wholly owned Japanese subsidiary, acquired development and commercialization rights to Loramyc (miconazole Lauriad) in Japan from BioAlliance Pharma.

11 May 2011

Elekta to integrate cancer workflow and patient management tools into IBA's Proteus TK2 center

Elekta, a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders, will integrate cancer workflow and patient management tools into the Proteus TK2, a turnkey proton therapy center from Belgium-based Ion Beam Applications.

From Elekta 10 May 2011

UCH to hold groundbreaking ceremony for $400M expansion at Anschutz Medical Campus

The University of Colorado Hospital is holding a groundbreaking ceremony to celebrate the $400 million expansion on Tuesday, May 24, from 5 to 6:30 p.m. at the Anschutz Medical Campus.

10 May 2011

Surgery reduces mortality risk of prostate cancer

A Swedish research team partly consisting of researchers from Uppsala University followed a group of prostate cancer patients in the Nordic region for 15 years. The study found, among other things, that surgery reduces the risk that men with prostate cancer (even those with low-risk tumours) will die within 15 years. The results were published today in the New England Journal of Medicine.

6 May 2011

Research experts to speak at brain tumor educational conference

Patients, families and caregivers are invited to attend an educational conference covering many aspects of brain tumors May 14 at Cedars-Sinai Medical Center.

5 May 2011

Thomas Jefferson University receives award to develop novel radiation drugs

Shortly before Japan's devastating nuclear incident, researchers at Thomas Jefferson University and Hospitals received an award to find novel drugs to treat people exposed to dangerous amounts of radiation in the wake of a nuclear terrorist attack or a nuclear accident.

5 May 2011

Acetyl resveratrol could protect against radiation sickness

In the midst of ongoing concerns about radiation exposure from the Fukushima nuclear power plant in Japan, scientists are reporting that a substance similar to resveratrol - an antioxidant found in red wine, grapes and nuts - could protect against radiation sickness. The report appears in ACS Medicinal Chemistry Letters.

5 May 2011

RaySearch Laboratories reports net sales of SEK 23.0 M for 2011

RaySearch Laboratories: "We have already noted a growing interest in RayStation® following the breakthrough in the US and Europe, and I am convinced that our customer list will grow during 2011," concludes Johan Löf.

4 May 2011

Tecnologie Avanzate, Naviscan sign deal to distribute PET scanner in Italy

Naviscan, Inc., the leader in 3D Molecular Breast Imaging, has entered into a distribution agreement with Tecnologie Avanzate s.r.l. to market and service Naviscan's high-resolution organ-specific PET scanner in Italy.

3 May 2011

Combining CT with FDG-PET improves treatment options for head, neck cancer patients

Combining computerized tomography with fluorodeoxyglucose positron emission tomography images results in significantly more defined tumor outlines and potentially different treatment options in head and neck cancer patients compared to using CT alone, according to research presented today, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta.

30 Apr 2011

Reimbursement policy influences choice of IMRT for treating breast cancer

What Medicare would pay for and where a radiation oncologist practiced were two factors that strongly influenced the choice of intensity-modulated radiation therapy (IMRT) for treating breast cancer, according to an article published April 29 online in the Journal of the National Cancer Institute. The use of IMRT and the cost of radiation therapy increased sharply over the period of the study.

29 Apr 2011

Annual mammogram sufficient follow-up after BCT for breast cancer patients

An annual mammogram is sufficient follow-up after breast conserving therapy (BCT) for breast cancer patients, according to a study presented today, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. This symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and Radiological Society of North America (RSNA).

29 Apr 2011

Proton radiography imaging helps lower radiation dosage to pediatric cancer patients

Proton radiography imaging used prior to and during proton treatments for pediatric cancer patients provides for more accurate treatment delivery and a lower dose of radiation compared to standard diagnostic X-rays and cone beam CT, according to a study presented today at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. The symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).

29 Apr 2011

Pelvic MRI scan identifies local recurrence of prostate cancer at low PSA levels

A pelvic MRI scan with IV contrast and rectal balloon is highly effective in identifying local recurrence even at low PSA values in prostate cancer patients with a rising or persistently elevated PSA after prostatectomy, according to a study presented April 29, 2011, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. The symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).

29 Apr 2011

Injecting tissue spacers reduces risk of radiation burns to rectum in prostate cancer patients

Injecting a tissue spacer in the prostate-rectal inter-space is an effective way to reduce the rectal dose for prostate cancer patients receiving radiation therapy, according to research presented April 30, 2011, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. This symposium is sponsored by the American Society for Radiation Oncology (ASTRO) and Radiological Society of North America (RSNA).

29 Apr 2011

Biodesix announces patient enrollment for VeriStrat CASTLE study in lung cancer

Biodesix announces the enrollment of initial subjects into CASTLE, the inaugural study of the Addario Lung Cancer Medical Institute.

29 Apr 2011

Northstar Healthcare acquires ownership interests in Texas based radiation therapy cancer treatment centers

Northstar Healthcare Inc. today announced that it entered into an agreement to acquire certain ownership interests in four physician owned radiation therapy cancer treatment centers from Dr. Chris Phan, a radiation oncologist. Dr. Phan is founder and Chief Executive Officer of Expert Oncology Network Solutions, LLC (EONS). EONS has been instrumental in developing and consulting with cancer centers across Texas.

28 Apr 2011

ASTRO develops new thoracic radiotherapy guideline

The American Society for Radiation Oncology has developed a guideline for the use of external beam radiation therapy, endobronchial brachytherapy and concurrent chemotherapy to palliate thoracic symptoms caused by advanced lung cancer. The guideline will be published in Practical Radiation Oncology, an official journal of ASTRO.

28 Apr 2011

Radiation Therapy News and Research

Further Reading

IsoRay third fiscal quarter sales increase 17%

Young scientists receive Intel Foundation top prize for groundbreaking cancer work

Sosei acquires rights to Loramyc in Japan from BioAlliance Pharma

Elekta to integrate cancer workflow and patient management tools into IBA's Proteus TK2 center

UCH to hold groundbreaking ceremony for $400M expansion at Anschutz Medical Campus

Surgery reduces mortality risk of prostate cancer

Research experts to speak at brain tumor educational conference

Thomas Jefferson University receives award to develop novel radiation drugs

Acetyl resveratrol could protect against radiation sickness

RaySearch Laboratories reports net sales of SEK 23.0 M for 2011

Tecnologie Avanzate, Naviscan sign deal to distribute PET scanner in Italy

Combining CT with FDG-PET improves treatment options for head, neck cancer patients

Reimbursement policy influences choice of IMRT for treating breast cancer

Annual mammogram sufficient follow-up after BCT for breast cancer patients

Proton radiography imaging helps lower radiation dosage to pediatric cancer patients

Pelvic MRI scan identifies local recurrence of prostate cancer at low PSA levels

Injecting tissue spacers reduces risk of radiation burns to rectum in prostate cancer patients

Biodesix announces patient enrollment for VeriStrat CASTLE study in lung cancer

Northstar Healthcare acquires ownership interests in Texas based radiation therapy cancer treatment centers

ASTRO develops new thoracic radiotherapy guideline

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News